Basilea Pharmaceutica Ltd (BPMUF)
OTC
Closed
Oct 6, 2026
Day's Range
76.2552 wk Range
59.29Overview - BPMUF - Basilea Pharmaceutica Ltd
Key Statistics
Valuation
Enterprise Value
1.05B
P/E (Trailing)
‪15.86‬
Price / Sales (TTM)
‪3.87‬
Price / Book
‪4.91‬
EV / EBITDA
‪14.28‬
Profitability
Profit Margin
‪21.17%‬
Operating Margin
‪26.89%‬
Return on Assets
‪13.68%‬
Return on Equity
‪39.45%‬
Ownership
Shares Outstanding
12.37M
Float
11.31M
Held by Insiders
‪0.61%‬
Held by Institutions
‪31.42%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪70.39‬
200-Day Avg
‪68.08‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BPMUF - Basilea Pharmaceutica Ltd
Peers - BPMUF - Basilea Pharmaceutica Ltd
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - BPMUF - Basilea Pharmaceutica Ltd
About
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company headquartered in Allschwil, Switzerland, founded in 2000 as a spin-off from F. Hoffmann-La Roche. With approximately 150 employees, it focuses on discovering, developing, and commercializing innovative anti-infective drugs to address severe…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
